Triptolide-based treatment prolongs symptom-free survival in preclinical medulloblastoma models

  • Post author:
  • Post category:uncategorized

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity.